Rain Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	37.31	61.96	24.78	58.86	5.79
Short-Term Investments	40.01	68.5	115.44	0	0
Cash & Cash Equivalents	77.32	130.45	140.22	58.86	5.79
Cash Growth	-14.76%	-6.96%	138.21%	915.93%	-
Other Current Assets	3.5	3.17	5.93	0.66	0.48
Total Current Assets	80.82	133.63	146.15	59.53	6.27
Property, Plant & Equipment	1.06	0.35	0.55	0.55	0.69
Other Long-Term Assets	0.18	1.2	0.44	1.01	0.43
Total Long-Term Assets	1.24	1.55	0.99	1.56	1.12
Total Assets	82.06	135.18	147.14	61.08	7.4
Accounts Payable	8.97	7.15	6.11	0.82	0.26
Current Debt	0.46	0.16	0.16	0.14	0.14
Other Current Liabilities	5.05	14.66	10.04	2.46	0.83
Total Current Liabilities	14.48	21.97	16.32	3.42	1.22
Long-Term Debt	0	0.11	0.25	0.31	3.18
Other Long-Term Liabilities	0.06	0.07	0.07	0.07	0.1
Total Long-Term Liabilities	0.06	0.18	0.32	0.38	3.27
Total Liabilities	14.54	22.14	16.64	3.8	4.5
Total Debt	0.46	0.28	0.41	0.45	3.31
Debt Growth	46.15%	-32.77%	-9.05%	-86.32%	-
Common Stock	282.85	278.89	220.56	1.15	0.24
Retained Earnings	-215.27	-165.69	-89.96	-38.57	-17.49
Comprehensive Income	-0.06	-0.17	-0.09	0	0
Shareholders' Equity	67.52	113.04	130.5	-37.42	-17.25
Net Cash / Debt	76.86	130.18	139.81	58.41	2.48
Net Cash / Debt Growth	-14.97%	-6.89%	139.35%	2253.34%	-
Net Cash Per Share	2.11	4.65	7.20	17.43	1.03
Working Capital	66.34	111.66	129.83	56.11	5.05
Book Value Per Share	1.86	4.04	6.72	-11.16	-7.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).